PATENT CLAIM ANALYSIS

Application Number: 15987039
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "001000"]

Abstract:
The method of this invention relates a method of diagnosing a patient as having post-traumatic stress disorder (PTSD) and/or treating the patient therapeutically for PTSD. In one embodiment, the treatment involves administering a therapeutically effective amount of bufodienolide antagonist to the patient.

Claim (Index 16):
A method of reducing the risk of PTSD in a patient who is suspected to have a propensity for developing PTSD, comprising administering to the patient a therapeutically effective amount of a MBG antagonist.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 93.0
- Lexical Diversity: 1.34286
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14169365', '13160735', '15306178', '11993309', '12821880']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7381513523281905
- 35 USC 102 Novelty (BERT): 0.4800499957655762
- Combined Prediction Score: 0.7123412166719292
- Mean Citation Score: 181.224256
- Max Citation Score: 205.65852
- Similarity Product: 161.2205236722851

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test